Z
0.850
-0.01 (-1.16%)
| Previous Close | 0.860 |
| Open | 0.888 |
| Volume | 36,826 |
| Avg. Volume (3M) | 43,617 |
| Market Cap | 88,537,704 |
| Price / Sales | 4.14 |
| Price / Book | 9.00 |
| 52 Weeks Range | |
| Earnings Date | 26 Jun 2024 |
| Operating Margin (TTM) | -44,930.90% |
| Diluted EPS (TTM) | -0.070 |
| Quarterly Revenue Growth (YOY) | -39.70% |
| Total Debt/Equity (MRQ) | 5.91% |
| Current Ratio (MRQ) | 2.20 |
| Operating Cash Flow (TTM) | -7.74 M |
| Levered Free Cash Flow (TTM) | -2.94 M |
| Return on Assets (TTM) | -27.09% |
| Return on Equity (TTM) | -47.77% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Zentek Ltd. | Mixed | Mixed |
AIStockmoo Score
0.7
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.67 |
|
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 6.01% |
| % Held by Institutions | 1.45% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Aspect Partners, Llc | 30 Sep 2024 | 1,666 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Dec 2024 | Announcement | Zentek Provides Update on International Opportunities |
| 09 Dec 2024 | Announcement | Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price |
| 27 Nov 2024 | Announcement | ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence |
| 06 Nov 2024 | Announcement | Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology |
| 31 Oct 2024 | Announcement | Zentek Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters |
| 17 Oct 2024 | Announcement | Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |